HNMPA-(AM)3 |
Catalog No.GC18888 |
HNMPA-(AM)3는 HNMPA의 세포 투과성 및 선택적 인슐린 수용체 티로신 키나제 억제제 유사체입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 120944-03-8
Sample solution is provided at 25 µL, 10mM.
HNMPA-(AM)3 is a cell-permeable prodrug form of the insulin receptor tyrosine kinase (IRTK) inhibitor HNMPA . HNMPA-(AM)3 inhibits IRTK autophosphorylation in CHO cells expressing the human receptor in a concentration- and time-dependent manner. It inhibits 2-deoxyglucose uptake but does not affect insulin-stimulated thymidine uptake in CHO cells at concentrations up to 100 μM.
Review for HNMPA-(AM)3
Average Rating: 5
(Based on Reviews and 33 reference(s) in Google Scholar.)Review for HNMPA-(AM)3
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *